Cargando…
Biorisk assessment for infrastructure & biosafety requirements for the laboratories providing coronavirus SARS-CoV-2/(COVID-19) diagnosis
Novel coronavirus infection [coronavirus disease 2019 (COVID-19)] has spread to more than 203 countries of various regions including Africa, America, Europe, South East Asia and Western Pacific. The WHO had declared COVID-19 as the global public health emergency and subsequently as pandemic because...
Autores principales: | Mourya, Devendra T., Sapkal, Gajanan, Yadav, Pragya D., M. Belani, Sujeet Kumar, Shete, Anita, Gupta, Nivedita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357401/ https://www.ncbi.nlm.nih.gov/pubmed/32242878 http://dx.doi.org/10.4103/ijmr.IJMR_763_20 |
Ejemplares similares
-
Certification & validation of biosafety level-2 & biosafety level-3 laboratories in Indian settings & common issues
por: Mourya, Devendra T., et al.
Publicado: (2017) -
Re-assessing the biosafety level requirement & defining surveillance need for Kyasanur forest disease virus: Changed paradigm
por: Mourya, Devendra T., et al.
Publicado: (2021) -
Difference in vector ticks dropping rhythm governs the epidemiology of Crimean-Congo haemorrhagic fever & Kyasanur forest disease in India
por: Mourya, Devendra T., et al.
Publicado: (2016) -
Zika virus: Indian perspectives
por: Mourya, Devendra T., et al.
Publicado: (2016) -
Establishment of Biosafety Level-3 (BSL-3) laboratory: Important criteria to consider while designing, constructing, commissioning & operating the facility in Indian setting
por: Mourya, Devendra T., et al.
Publicado: (2014)